Brief: Onxeo Receives EPO Intent-to-Grant Notice for New Patent Protecting AsiDNA in Combination with Any PARP Inhibitor
Dec 18 (Reuters) - Onxeo SA C4X.PA :
* ONXEO RECEIVES EPO INTENT-TO-GRANT NOTICE FOR NEW PATENT
PROTECTING ASIDNA™ IN COMBINATION WITH ANY PARP INHIBITOR
* COMBINATION PATENT TO BE GRANTED IN EUROPE UNTIL 2036
Source text for Eikon: ID:nBw4PmLNna
Further company coverage: C4X.PA
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Valerio Therapeutics SA
See all newsBrief: Valerio Therapeutics To Buy Etherna Immunotherapies For €30 Mln
Brief: Valerio Therapeutics Signs Development Collaboration With Abivax
Brief: Valerio Therapeutics Enters Into Collaboration & Exclusive License With Seed-Stage Biotech Co
Brief: Onxeo Changes Its Name And Becomes Valerio Therapeutics
Brief: Onxeo H1 Net Loss Widens To EUR 11.5 Mln